MORGAN BITZEL: Open Payments
NPI 1144974056 · WORTHINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 25 payments from 13 companies in 2025. Trend: 2023 $105 · 2024 $484 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $324 |
| IMMUNITYBIO, INC. | 2 | $211 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $185 |
| Boston Scientific Corporation | 1 | $71 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| UROGEN PHARMA, INC. | 2 | $60 |
| ABBVIE INC. | 1 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| MIMEDX Group, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: GEMTESA, ANKTIVA, JOURNAVX, General - Kidney Stone Disease, KEYTRUDA, ORGOVYX, JELMYTO, BOTOX.
Industry payments across OH — which companies pay providers there.
